USA - February 17 2022
In 2020, the Patent Trial and Appeal Board (“PTAB”) announced six factors to be used in determining whether to institute an inter partes review…
William A. Meunier, Serge Subach
USA - January 21 2022
Earlier this month, in Novartis Pharms. Corp., Inc. v. Accord Healthcare, Inc., et al., No. 2021-1070, the Federal Circuit issued a helpful decision…
Meena Seralathan
USA - January 21 2022
Recently, the U.S. Patent and Trademark Office (“USPTO”) published a notice informing the public that it will be implementing a pilot program (called…
Meena Seralathan
USA - January 19 2022
On January 3, 2022, Magistrate Judge Susan Hightower granted a defendant’s motion to exclude an expert’s damages theory for violating the entire…
Marguerite McConihe, Robert C. Sweeney
USA - January 14 2022
As a Patent Owner in an instituted Inter Partes Review (IPR), there are dozens of considerations to bear in mind - from strategically approaching…
William A. Meunier, Michael T. Renaud